Morten Albrechtsen
Chief Executive Officer chez FLUOGUIDE A/S
Fortune : 7 M $ au 31/03/2024
Profil
Morten Albrechtsen is the founder of Nanovi Radiotherapy A, which was founded in 2012.
He currently holds the position of Chief Executive Officer & Director at Appium Partners, Chief Executive Officer at Komplementar Appium Partners Ivs, Chief Executive Officer at Webequ Ivs, Chief Executive Officer at FluoGuide A, Chairman at Retipharma Ivs, and Director at Wexotec Invest ApS.
Dr. Albrechtsen's former positions include Chief Executive Officer at ENKAM Pharmaceuticals A, Chief Executive Officer & Director at InnoCC ApS, Chairman at Wear&Care ApS, Chairman at Pulmotrace ApS, and Investment Manager at Accelerace Management A.
Dr. Albrechtsen has also held positions such as Area Director at Takeda A and Product Manager at Boehringer Ingelheim Danmark A.
Dr. Albrechtsen has an undergraduate degree from Copenhagen Business School and a doctorate from the University of Copenhagen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FLUOGUIDE A/S
12,20% | 30/09/2023 | 1 488 610 ( 12,20% ) | 7 M $ | 31/03/2024 |
Postes actifs de Morten Albrechtsen
| Sociétés | Poste | Début |
|---|---|---|
| FLUOGUIDE A/S | Chief Executive Officer | 01/01/2018 |
| Webequ Ivs | Chief Executive Officer | - |
Retipharma Ivs
 Retipharma Ivs Pharmaceuticals: MajorHealth Technology Retipharma Ivs develops drugs for eye disorders. The company is based in Copenhagen, Denmark. | Chairman | 01/04/2018 |
| Komplementar Appium Partners Ivs | Chief Executive Officer | - |
| Wexotec Invest ApS | Director/Board Member | - |
| Appium Partners | Chief Executive Officer | - |
Anciens postes connus de Morten Albrechtsen
| Sociétés | Poste | Fin |
|---|---|---|
| COMBIGENE AB | Director/Board Member | 16/05/2019 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Chief Executive Officer | 31/05/2018 |
InnoCC ApS
 InnoCC ApS Medical SpecialtiesHealth Technology InnoCC ApS manufactures and develops medical devices for critical care units, which measure heart and lung function non-invasively on the basis of gas exchange in the lungs. It also develops devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. The company was founded in 2014 and is headquartered in Odense, Denmark. | Chief Executive Officer | 01/09/2015 |
| ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formation de Morten Albrechtsen
| Copenhagen Business School | Undergraduate Degree |
| University of Copenhagen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COMBIGENE AB | Health Technology |
| FLUOGUIDE A/S | Health Technology |
| Entreprise privées | 19 |
|---|---|
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Biohemp International, Inc.
 Biohemp International, Inc. Pharmaceuticals: MajorHealth Technology Biohemp International, Inc. operates as a pharmaceutical company, which provides insomnia remedy. The firm has developed Zleepax, which is a sleep aid with beta blockers as the major active agent. The company was founded by Briger Jan Olsen on August 11, 2012 and is headquartered in New York, NY. | Health Technology |
Norma AS
 Norma AS TextilesProcess Industries Norma AS is engaged in the production and sale of safety systems and details for automobiles. Its operations are carried out through the following business segments: Car safety belts, Seat belt components, Car parts, Tooling, and Real estate activities. The company was founded in 1891 and is headquartered in Tallinn, Estonia. | Process Industries |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
Cabra Technology A/S
 Cabra Technology A/S Medical SpecialtiesHealth Technology Cabra Technology A/S is a holding company that provides medical imaging systems. It develops method for calculating the risk of catastrophic stroke. Its magnetic resonance imaging scans are used to generate computational models, simulating the blood-flow inside the carotid arteries, and the biomechanical stresses caused thereby inside atherosclerotic plaques. The company was founded by Jens Vinge Nygaard on July 1, 2009 and is headquartered in Aalborg, Denmark. | Health Technology |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
Accelerace Management A/S
 Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Finance |
| Appium Partners | |
InnoCC ApS
InnoCC ApS Medical SpecialtiesHealth Technology InnoCC ApS manufactures and develops medical devices for critical care units, which measure heart and lung function non-invasively on the basis of gas exchange in the lungs. It also develops devices and modules for non-invasive measurement of cardiac output, oxygen uptake, and functional residual capacity. The company was founded in 2014 and is headquartered in Odense, Denmark. | Health Technology |
NociTech ApS
 NociTech ApS BiotechnologyHealth Technology NociTech ApS develops a novel pain assessment platform for pain treatment. It provides a test platform to quantify pain sensitivity in patients and profile new analgesic compounds under development. The company was founded by Lars Arendt-Nielsen on July 11, 2013 and is headquartered in Aalborg, Denmark. | Health Technology |
JGN 1 3-12-2018 ApS
 JGN 1 3-12-2018 ApS Medical SpecialtiesHealth Technology JGN 1 3-12-2018 ApS develops and manufactures medical devices. Its products include Innocor, an instrument measuring cardiac output non-invasively; and AMIS 2000 The company is headquartered in Glamsbjerg, Denmark. | Health Technology |
Pulmotrace ApS
 Pulmotrace ApS Electronic Equipment/InstrumentsElectronic Technology Pulmotrace ApS produces sells, and services the product Innocor in EU, Canada, and United States. It develops a device that enables easier and more accurate measurement of lung function. The company is headquartered in Glamsbjerg, Denmark. | Electronic Technology |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Process Industries |
Retipharma Ivs
Retipharma Ivs Pharmaceuticals: MajorHealth Technology Retipharma Ivs develops drugs for eye disorders. The company is based in Copenhagen, Denmark. | Health Technology |
Boehringer Ingelheim Danmark A/S
 Boehringer Ingelheim Danmark A/S Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Danmark A/S develops, produces, markets and sells pharmaceutical products. The company was founded in 1974 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Wexotec Invest ApS | |
Wear&Care ApS
 Wear&Care ApS Services to the Health IndustryHealth Services Wear&Care ApS develops and implements welfare technological solutions. It specializes in overcome of diseases which include dementia, sclerosis, parkinson, brain damage, cerebral paralysis, spinal diseases, and various physical handicaps. The company was founded by Martin Ettrup Hansen and Helle Thambo Andersen in 2012 and is headquartered in Odense, Denmark. | Health Services |
| Komplementar Appium Partners Ivs | |
| Webequ Ivs |
